Concepedia

Birgit De Beleyr

BD

4

Publications

261

Citations

4

H-Index

2016

Active since

Affiliations

Pfizer (Belgium)(Current)

Janssen (Belgium)

Ghent University Hospital

KU Leuven

UCLouvain

Birgit De Beleyr is an author at Pfizer (Belgium) specializing in rheumatology, rheumatic diseases, and rheumatoid arthritis.

Top concepts

Publications per year

2016–2022

4

Publications

4

Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium

Liese Vandeborne, Eline van Overbeeke, Marc Dooms et al. · Orphanet Journal of Rare Diseases · 2019 · 161 citations · Full text

Perception of Originator Biologics and Biosimilars: A Survey Among Belgian Rheumatoid Arthritis Patients and Rheumatologists

Eline van Overbeeke, Birgit De Beleyr, Jan de Hoon et al. · BioDrugs · 2017 · 77 citations

, , +5

Gastrointestinal risk assessment in patients requiring non-steroidal anti-inflammatory drugs for osteoarthritis: The GIRANO study

Guy Vanderstraeten, Thierry Lejeune, Hubert Piessevaux et al. · Journal of Rehabilitation Medicine · 2016 · 12 citations · Full text

Effectiveness and Safety of Ibrutinib for Chronic Lymphocytic Leukemia in Routine Clinical Practice: 3-Year Follow-up of the Belgian Ibrutinib Real-World Data (BiRD) Study

Ann Janssens, Zwi Berneman, Fritz Offner et al. · Clinical Hematology International · 2022 · 11 citations · Full text

Rows per page

1–4 of 4